Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep832 | Clinical case reports - Pituitary/Adrenal | ECE2017

Coexistence of TSH-secreting pituitary adenoma, primary hyperparathyroidism and vitamin D deficiency

Oueslati Ibtissem , Mchirgui Nadia , Khiari Karima , Abdallah Nejib Ben

Introduction: The simultaneous occurrence of central hyperthyroidism and primary hyperparathyroidism is extremely rare. Few cases of TSH pituitary adenoma in the setting of multiple endocrine neoplasia type 1-associated syndrome were reported in literature. Herein, we report a new case of TSH secreting pituitary adenoma particular by the coexisting of primary hyperparathyroidism and vitamin D deficiency.Observation: A 76-year-old woman was referred to ou...

ea0011p20 | Bone | ECE2006

Treatment and follow up of primary hyperparathyroidism: 50 cases

Cheikhrouhou Hela , Ali Insaf Hadj , Khiari Karima , Abdallah Nejib Ben

We report a retrospective study of 50 cases of primary hyperparathyroidism (10 men and 40 women, mean age: 49 years) collected between 1975 and 2004. At the time of diagnosis, 44% of patients had bone disease, renal manifestations were present in 17 cases (34%).Parathyroidectomy is a safe and effective approach of primary hyperparathyroidism treatment. The management of persistent or recurrent hyperparathyroidism is explained by the fact that parathyroid...

ea0011p318 | Diabetes, metabolism and cardiovascular | ECE2006

Cardiovascular risk factors and macrovascular complications in type 2 diabetes

Khiari Karima , Cheikhrouhou Hela , Ali Insaf Hadj , Abdallah Nejib Ben

The frequency of type 2 diabetes increases in all of the world. The risk for atherosclerosis vascular disease is greatest in type 2 diabetic patients who have other known risk factors such obesity, smoking, hypertension and dyslipidemia.The aim of our study is to determine the frequency of cardiovascular risk factors associated to diabetes and the frequency of macrovascular complications in type 2 diabetic patients.It is a retrospe...

ea0011p481 | Endocrine tumours and neoplasia | ECE2006

Macroprolactinoma: 5 cases

Hadj Ali Insaf , Cheikhrouhou Hela , Khiari Karima , Ben Abdallah Nejib

Prolactinoma represents 27 to 35% of pituitary adenomomas and 40 to 75% of secreting adenomas. However, the macroprolactinomas are not frequent. We report clinical, biological and therapeutic aspects of 5 cases of macroprolactinomas. It concerns 3 women and 2 men. The average age is 43.4 years (19–68). The reason for seaking medical advice was amenorrhea – galactorrhea syndrom in 2 women and infertility in one case. The diagnosis of pituitary adenoma is incidentally ...

ea0081p367 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metformine: anti-fibrotic molecule?

Khelifi Dayssem , Ben Nacef Ibtissem , Bouzid Kahena , Rojbi Imen , Lakhoua Youssef , Mchirgui Nadia , Khiari Karima

Background and aims: Diabetes causes tissue fibrosis by still poorly understood mechanisms which involve glycation products. Galectin-3 (Gal-3) is an emerging key player in metabolic disorders and a powerful factor in the development and progression of the fibrotic process in target organs in diabetic patients. The plasma level of Gal-3 increases during diabetic cardiomyopathy and diabetic nephropathy. We have studied the correlation between serum Gal-3 level and anti-diabetic...

ea0081p374 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Threshold value of galectine-3 in a Tunisian diabetic population

Khelifi Dayssem , Nacef Ibtissem Ben , Bouzid Kahena , Rojbi Imen , Lakhoua Youssef , Mchirgui Nadia , Khiari Karima

Background and aims: Plasma Galectin-3 (Gal-3), mediator of fibrogenesis and inflammation, has been implicated in many diseases. Particularly in diabetics, this lectin directly mediates transdifferentiation in collagen-producing cells thus leading to fibrosis of target organs and accelerating the development of complications. The objective of our study was to determine a cut-off value for Gal-3 in our population.Methods: We conducted a cross-sectional, a...

ea0081ep95 | Adrenal and Cardiovascular Endocrinology | ECE2022

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and hypertension: a case report

Besrour Chayma , Imen Rojbi , Sabrine Mekni , Marwa Majdoub , Youssef Lakhoua , Ibtissem Ben Nacef , Karima Khiari

Introduction: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most common of the CAH, it is also the most common of the autosomal recessive diseases. Hypertension is generally absent, and its presence should lead to an investigation of another cause.Observation: We report the case of a 26-year-old young man, descendant from a second-degree consanguineous marriage with a family history of the death of a brother at the age of 2...

ea0081ep178 | Calcium and Bone | ECE2022

Sickle cell disease and hyperparathyroidism: case report

Jridi Maysam , Mekni Sabrine , Meriem Adel , Rojbi Imen , Nacef Ibtissem Ben , Mchirgui Nadia , Khiari Karima

Introduction: Primary hyperparathyroidism (pHPT) is a common endocrine disorder usually diagnosed by the presence of elevated serum calcium levels with inappropriate normal or increased parathyroid hormone (PTH) serum levels. This condition has been reported in few cases of patients with sickle cell disease (SCD), a multisystem disorder with acute and chronic complications.Observation: We report a case of a 63-year-old Tunisian woman with a history of ho...

ea0081ep201 | Calcium and Bone | ECE2022

Chronic asymptomatic hypocalcemia following thyroid surgery

Gharbi Mohamed , Mekni Sabrine , Rojbi Imen , Lakhoua Youssef , Mchirgui Nadia , Nacef Ibtissem Ben , Khiari Karima

Introduction: Postoperative hypoparathyroidism is a frequent complication of total thyroidectomy that must be detected and treated. The resulting hypocalcemia is quite severe and usually occurs in the first few days or weeks after surgery.Herein, we describe a case of chronic asymptomatic hypocalcemia related to postoperative hypoparathyroidism diagnosed years after total thyroidectomy.Observation: We report the case of a 61 year old woman, who had a tot...

ea0081ep235 | Calcium and Bone | ECE2022

Association between primary hyperparathyroidism with severe bone disease and osteomalacia: A case report.

Khiari Hager , Rojbi Imen , Smadhi Houaida , Mekni Sabrine , Lakhoua Youssef , Nacef Ibtissem Ben , Khiari Karima

Introduction: Primary hyperparathyroidism is associated with multiple complications: severe bone disease is one of them. Osteomalacia is by definition a metabolic bone disease characterized by a softening of the bones. We herein report a rare case of an association between primary hyperparathyroidism with osteitis fibrosa cystica and osteomalacia caused by a severe vitamin D deficiency.Observation: A 37-year old woman was referred for investigation of we...